Xiaolin Zhang

Title: Innovations by Xiaolin Zhang in Eukaryotic Cell Stability

Introduction

Xiaolin Zhang is a notable inventor based in Iselin, NJ (US). He has made significant contributions to the field of biotechnology, particularly in enhancing the stability of eukaryotic cell lines. His work is crucial for the production of recombinant products, which have various applications in medicine and research.

Latest Patents

Xiaolin Zhang holds a patent titled "Method to alter Chinese hamster ovary cell line stability." This invention provides a recombinant eukaryotic cell that expresses one or more heterologous double strand break (DSB) repair proteins. The patent aims to enhance DSB repair in the cell, which is vital for improving the production of recombinant products of interest. The methods outlined in the patent also include establishing host cells for production, enhancing DSB repair, and investigating the suitability of eukaryotic cells as host cells.

Career Highlights

Xiaolin Zhang is affiliated with the University of Delaware, where he continues to advance research in cell line stability and recombinant product production. His innovative approaches have positioned him as a key figure in the biotechnology sector.

Collaborations

Xiaolin collaborates with Kelvin Lee, a fellow researcher, to further explore advancements in eukaryotic cell applications. Their combined expertise enhances the potential for breakthroughs in the field.

Conclusion

Xiaolin Zhang's contributions to biotechnology through his patent and research at the University of Delaware highlight the importance of innovation in enhancing eukaryotic cell stability. His work is paving the way for future advancements in the production of recombinant products.